Cell surface heparan sulfate proteoglycans (HSPGs) are abundant, ubiquitous molecules, that bind via heparan sulfate (HS) chains to growth factors, extracellular matrix proteins, and other important cellular effectors. The major cell surface HSPGs are products of two gene families: the syndecans, which are transmembrane proteins, and the glypicans, which are glycosylphosphatidylinositol-anchored. Four syndecans and at least five glypicans are expressed in mammals, including man. The biological functions of cell surface HSPGs are poorly understood, but at least one function involves regulation of the responses of cells to polypeptide growth factors. Recently, a human birth defects syndrome associated with dysregulated tissue growth was shown to be caused by null mutations in glypican-3. Genetic studies in the fruitfly, Drosophila, have also linked loss of glypican function to defects in tissue growth and patterning. One tissue in which glypicans are likely to play especially important development roles is the nervous system. Experiments with cultured neutral cells and lower organisms have long pointed to crucial roles for HSPGs in neutral patterning, axon guidance, and synapse formation. Previous work on this project has demonstrated that glypicans-1 and -2 are among the most abundant HSPGs in the mammalian brain, and are expressed in locations such as neutral precursor zones, growing axons, and synaptic terminal fields, that are consistent with playing such developmental roles. The goals for the next project period focus on uncovering the functions of glypicans-1 and -2 in the mammalian nervous system, and on relating glypican function to structural features of the glypicans, such as the presence of HS chains, the mode of membrane anchorage, and presence of a large N- terminal globular domain that does not carry HS, yet has been highly conserved throughout evolution. Functional experiments involve the analysis of mice engineered to lack glypican-1, glypican-2, or both. Glypican-2 null mice have already been made, and the generation of glypican-1 null mice is in progress. Analysis of structure-function relationships in glypicans will use the fruitfly as an experimental system in which genes encoding altered glypicans can be rapidly and quantitatively tested for function. Finally, the results of observing mutant phenotypes and making structure/function correlations will be used to direct a genetic and biochemical search for the ligands with which glypicans interact in mammalian nervous system development. These studies should provide insights into how an important and poorly understood class of molecules regulates basic developmental processes, particularly in the nervous system.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS026862-10
Application #
2891739
Study Section
Pathobiochemistry Study Section (PBC)
Program Officer
Finkelstein, Robert
Project Start
1990-04-01
Project End
2005-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
10
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California Irvine
Department
Anatomy/Cell Biology
Type
Schools of Arts and Sciences
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Potkin, Steven G; Macciardi, Fabio; Guffanti, Guia et al. (2010) Identifying gene regulatory networks in schizophrenia. Neuroimage 53:839-47
Jen, Yi-Huei Linda; Musacchio, Michele; Lander, Arthur D (2009) Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis. Neural Dev 4:33
Ding, Kan; Lopez-Burks, Martha; Sanchez-Duran, Jose Antonio et al. (2005) Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells. J Cell Biol 171:729-38
Murray, Richard C; Navi, Daniel; Fesenko, John et al. (2003) Widespread defects in the primary olfactory pathway caused by loss of Mash1 function. J Neurosci 23:1769-80
Lander, Arthur D; Nie, Qing; Wan, Frederic Y M (2002) Do morphogen gradients arise by diffusion? Dev Cell 2:785-96
Chen, R L; Lander, A D (2001) Mechanisms underlying preferential assembly of heparan sulfate on glypican-1. J Biol Chem 276:7507-17
Matsuda, K; Maruyama, H; Guo, F et al. (2001) Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res 61:5562-9
Emerling, D E; Lander, A D (2000) Using organotypic tissue slices as substrata for the culture of dissociated cells. Methods Mol Biol 139:245-56
Herndon, M E; Stipp, C S; Lander, A D (1999) Interactions of neural glycosaminoglycans and proteoglycans with protein ligands: assessment of selectivity, heterogeneity and the participation of core proteins in binding. Glycobiology 9:143-55
Litwack, E D; Ivins, J K; Kumbasar, A et al. (1998) Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent. Dev Dyn 211:72-87

Showing the most recent 10 out of 30 publications